Global AI health tools expose regulatory gaps, equity risks, and corporate influence across health systems
Original framing: “AI in healthcare is an evolving landscape of new technologies, productivity benefits and legal uncertainties” — The Conversation - Global
Rigorous validation studies show that AI algorithms can inherit biases from training datasets, leading to disparate error rates across race, gender, and socioeconomic status. Peer‑reviewed meta‑analyses call for transparent reporting, external validation, and post‑deployment monitoring to ensure safety and efficacy.
The proliferation of AI in health reflects a convergence of corporate ambition, fragmented regulatory landscapes, and historic patterns of technology rollout that have repeatedly disadvantaged marginalised communities.
By integrating indigenous data sovereignty, cross‑cultural governance models, and rigorous scientific validation, a co‑created regulatory framework can transform AI from a source of uncertainty into a tool for equitable care. Participatory stewardship and universal safety certification will embed accountability, while workforce reskilling ensures that human expertise remains central. Together, these mechanisms draw on past lessons, present ethical imperatives, and future scenario planning to re‑anchor AI within a health system that serves all peoples rather than a privileged few.